Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glaxosmithkline Plc Reaffirms FY 2013 Guidance; Declares First Interim Dividend


Wednesday, 24 Apr 2013 07:00am EDT 

Glaxosmithkline Plc announced for fiscal 2013, it expects sales growth of approximately 1% and core EPS growth 3-4% unchanged (both at CER). The Company reported revenue of $42.025 billion and EPS of $3.53 in fiscal 2012. The Company also announced that the Board has declared a first interim dividend of 18 pence per share (first quarter of 2012: 17 pence per share). The equivalent interim dividend receivable by ADR holders is 55.0224 cents per ADS based on an exchange rate of GBP1/$1.5284. The ex-dividend date will be May 08, 2013, with a record date of May 10, 2013 and a payment date of July 11, 2013.